ALEC
Alector, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:D+
Company Profile
CEO
Arnon Rosenthal
IPO Date
2019-02-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Alector, Inc.
CEO
Arnon Rosenthal
IPO Date
2019-02-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 28,700 |
| $0.00 |
| 17 Jun 2026 | Yaffe Kristine | director | A-Award | Acquired | 9,450 | $0.00 |
| 17 Jun 2026 | SCHELLER RICHARD H | director | A-Award | Acquired | 28,700 | $0.00 |
| 17 Jun 2026 | SCHELLER RICHARD H | director | A-Award | Acquired | 9,450 | $0.00 |
| 17 Jun 2026 | Hammond Paula | director | A-Award | Acquired | 28,700 | $0.00 |
| 17 Jun 2026 | Hammond Paula | director | A-Award | Acquired | 9,450 | $0.00 |
| 17 Jun 2026 | GAROFALO ELIZABETH A. | director | A-Award | Acquired | 28,700 | $0.00 |
| 17 Jun 2026 | GAROFALO ELIZABETH A. | director | A-Award | Acquired | 9,450 | $0.00 |
| 17 Jun 2026 | Altmeyer Mark | director | A-Award | Acquired | 28,700 | $0.00 |